Acumen Pharmaceuticals

Acumen Stock Crashes 91%: Its Only Drug Just Failed in Alzheimer's

2026-10-30

Acumen Pharmaceuticals (NASDAQ: ABOS) lost more than nine-tenths of its value in a single session on Friday, October 30, 2026, closing at $0.21 — down 90.8% from Thursday's $2.29 close — after the...